Concourse Financial Group Securities, Inc. Zentek Ltd. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.7 - $1.06 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.02 - $1.21 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.17 - $1.55 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.04 - $1.35 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.19 - $1.66 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.19 - $1.66 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.4 - $1.7 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.41 - $1.71 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.33 - $1.94 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.62 - $2.36 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.52 - $3.08 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.93 - $3.92 $0 - $0

Others Institutions Holding ZTEK

# of Institutions

Shares Held

1.47M

Call Options Held

Put Options Held

View Full List

About Zentek Ltd.

Ticker ZTEK
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 99,363,104
Market Cap $117M
Description
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detec...

More about ZTEK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account